247 related articles for article (PubMed ID: 37041393)
1. Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver "Triple Screen".
Low G; Ferguson C; Locas S; Tu W; Manolea F; Sam M; Wilson MP
Abdom Radiol (NY); 2023 Jun; 48(6):2060-2073. PubMed ID: 37041393
[TBL] [Abstract][Full Text] [Related]
2. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.
Alsaqal S; Hockings P; Ahlström H; Gummesson A; Hedström A; Hulthe J; Johansson L; Niessen HG; Schoelch C; Schultheis C; Vessby J; Wanders A; Rorsman F; Ebeling Barbier C
J Magn Reson Imaging; 2022 Aug; 56(2):368-379. PubMed ID: 34953171
[TBL] [Abstract][Full Text] [Related]
3. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
[TBL] [Abstract][Full Text] [Related]
4. MRI-derived proton density fat fraction.
Yoshizawa E; Yamada A
J Med Ultrason (2001); 2021 Oct; 48(4):497-506. PubMed ID: 34669068
[TBL] [Abstract][Full Text] [Related]
5. Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
Fowler KJ; Venkatesh SK; Obuchowski N; Middleton MS; Chen J; Pepin K; Magnuson J; Brown KJ; Batakis D; Henderson WC; Shankar SS; Kamphaus TN; Pasek A; Calle RA; Sanyal AJ; Loomba R; Ehman R; Samir AE; Sirlin CB; Sherlock SP
Radiology; 2023 Oct; 309(1):e231092. PubMed ID: 37815451
[TBL] [Abstract][Full Text] [Related]
6. Imaging biomarkers of NAFLD, NASH, and fibrosis.
Ajmera V; Loomba R
Mol Metab; 2021 Aug; 50():101167. PubMed ID: 33460786
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease.
Schaapman JJ; Tushuizen ME; Coenraad MJ; Lamb HJ
J Magn Reson Imaging; 2021 Jun; 53(6):1623-1631. PubMed ID: 32822095
[TBL] [Abstract][Full Text] [Related]
8. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.
Kim JW; Lee YS; Park YS; Kim BH; Lee SY; Yeon JE; Lee CH
Sci Rep; 2020 Feb; 10(1):2671. PubMed ID: 32060386
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.
Hanniman E; Costa AF; Bowen CV; Abdolell M; Stueck A; McLeod M; Peltekian K; Rioux J; Clarke SE
J Magn Reson Imaging; 2022 Nov; 56(5):1448-1456. PubMed ID: 35285996
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis B.
Hui RW; Chiu KW; Mak LY; Chang HC; Cheung KS; Fung J; Yuen MF; Seto WK
J Gastroenterol Hepatol; 2022 Jun; 37(6):1139-1147. PubMed ID: 35368120
[TBL] [Abstract][Full Text] [Related]
13. Clinical Application of Quantitative MR Imaging in Nonalcoholic Fatty Liver Disease.
Tsujita Y; Sofue K; Ueshima E; Ueno Y; Hori M; Murakami T
Magn Reson Med Sci; 2023 Oct; 22(4):435-445. PubMed ID: 35584952
[TBL] [Abstract][Full Text] [Related]
14. Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists.
Guglielmo FF; Barr RG; Yokoo T; Ferraioli G; Lee JT; Dillman JR; Horowitz JM; Jhaveri KS; Miller FH; Modi RY; Mojtahed A; Ohliger MA; Pirasteh A; Reeder SB; Shanbhogue K; Silva AC; Smith EN; Surabhi VR; Taouli B; Welle CL; Yeh BM; Venkatesh SK
Radiographics; 2023 Jun; 43(6):e220181. PubMed ID: 37227944
[TBL] [Abstract][Full Text] [Related]
15. Quantitative magnetic resonance imaging for chronic liver disease.
Moura Cunha G; Navin PJ; Fowler KJ; Venkatesh SK; Ehman RL; Sirlin CB
Br J Radiol; 2021 May; 94(1121):20201377. PubMed ID: 33635729
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.
Troelstra MA; Witjes JJ; van Dijk AM; Mak AL; Gurney-Champion O; Runge JH; Zwirs D; Stols-Gonçalves D; Zwinderman AH; Ten Wolde M; Monajemi H; Ramsoekh S; Sinkus R; van Delden OM; Beuers UH; Verheij J; Nieuwdorp M; Nederveen AJ; Holleboom AG
J Magn Reson Imaging; 2021 Dec; 54(6):1937-1949. PubMed ID: 33991378
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease.
Lee HA; Kim SS; Choi JY; Seo YS; Park BJ; Sim KC; Kim SU
Abdom Radiol (NY); 2022 Nov; 47(11):3733-3745. PubMed ID: 35962809
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease.
Lee YS; Yoo YJ; Jung YK; Kim JH; Seo YS; Yim HJ; Kim IH; Lee SY; Kim BH; Kim JW; Lee CH; Yeon JE; Kwon SY; Um SH; Byun KS
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00157. PubMed ID: 32251018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
